Parkinson’s Patients with Severe Pain Benefit from Oxycodone-Naloxone Treatment
In a recent paper published in The Lancet Neurology, researchers evaluated the analgesic effect of prolonged-release oxycodone-naloxone (OXN PR) in patients…
Articles by Margarida Rodrigues
Cell Death in Parkinson’s Disease Associated With New Genetic Mutation
Parkinson’s disease is still the second most common neurodegenerative disorder affecting millions of people worldwide. A multidisciplinary team of researchers…